FNAM.US Evolutionary Genomics Inc

Healthcare Biotechnology USA Stocks
0.0002 USD
Close of Oct 28, 2026
0.0002 0.0002
Market cap
USD 1.33K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is FNAM.US undervalued?

Graham number

The Graham number of Evolutionary Genomics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Evolutionary Genomics Inc fundamental analysis

No fundamental analysis for Evolutionary Genomics Inc yet.

Evolutionary Genomics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Evolutionary Genomics Inc

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company also develops Adapted Traits Platform, which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Cas…

Full company profile